20
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Correlation of Marrow Iron Patterns with Disease Status of Chronic Myelogenous Leukemia

&
Pages 469-475 | Received 24 Dec 1992, Published online: 01 Jul 2009

References

  • Cervantes F., Rozman C., Brugues R., Lianas I. Iron stores in chronic myelogenous leukaemia at presentation. Scand. J. Haematol. 1984; 32: 469–474
  • Sokal J. E., Sheerin K. A. Decreased stainable iron in chronic myelogenous leukemia. Am. J. Med. 1986
  • Cervantes F., Rozman C., Piera C., Fernandez M. R. Decreased bone marrow iron in chronic myelogenous leukemia: a consistent finding not reflecting iron deficiency. Blut. 1986; 53: 305–308
  • Cervantes F., Marti J. M., Piera C., Reverter J. C., Rozman C. Longitudinal study of serum ferritin concentrations in chronic myelogenous leukaemia. Acta Hae-matolog. 1988; 80: 13–16
  • Meredith J. T., Cerezo L. A comparison of stain-able iron in thick marrow aspirate smears and decalcified biopsy specimens. Lab. Med. 1988; 19: 493–496
  • Sundberg R. D., Broman H. The application of the prussian blue stain to previously stained films of blood and bone marrow. Blood 1955; 10: 160–166
  • Nixon R. K., Olson J. P. Diagnostic value of marrow hemosiderin patterns. Ann. Intern. Med. 1968; 69: 1249–1254
  • Jandl J. H. Blood. Textbook of Hematology, First edition. Little Brown and Company, Boston 1988; 671–689
  • Kent S., Weinberg E. Hypoferremia: adaptation to disease?. N. Engt. J. Med. 1989; 320: 672
  • Jakobsen E., Engeset A., Sanstand B., Aas M. Serum ferritin and bone marrow haemosiderin in patients with malignancies and in healthy controls. Scand. J. Haematol. 1982; 28: 264–271
  • Taetle R., Rhyner K., Castagnota J., To D., Mendelsohn J. Role of transferrin, iron, and transieron receptors in myeloid leukemia cell growth. J. Clin. Investig. 1985; 75: 1061–1067
  • Guimaraes J. E. T. E., Berney J. J., Broxmeyer H. E., Hoffbrand A. V., Francis P. E. Acidic isoferritin stimulates differentiation of normal granulomonocytic progenitors. Leukemia 1988; 2: 466–471

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.